Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 20, 2024 5:08 PM 2 min read

Hedge Funder Linked To Credit Suisse Collapse Gets 18 Year Prison Sentence For Fraud, Market Manipulation

by Erica Kollmann Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Archegos Capital Management founder Bill Hwang was sentenced on Wednesday to 18 years in prison for fraud and market manipulation tied to the fund's dramatic collapse in 2021. 

The Details: Hwang was sentenced by U.S. District Judge Alvin Hellerstein in New York to slightly less time than the 21 years prosecutors had sought in the case. 

Hwang's lawyers had asked that he be given no prison time at all and Hwang asked the judge on Wednesday to impose a sentence that would allow him to continue to serve society. He also said that he felt "deep pain" about what happened at Archegos, according to a Bloomberg report.

Read More: Trump Appears ‘Frustrated’ As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List 

Hellerstein said Hwang's request for no jail time was "utterly ridiculous" considering the amount of money involved. 

"The amount of losses that were caused by your conduct are larger than any amount of losses I've deal with as a judge," Hellerstein said.

The judge also compared Hwang to FTX founder Sam Bankman-Fried, who received a 25-year sentence for fraud.

"What was worse? Mr. Bankman-Fried's fraud or Mr. Hwang's fraud?" Hellerstein asked.

Former Archegos CFO Patrick Halligan was convicted alongside Hwang earlier in 2024 and will be sentenced separately in January.

Read Next: 

  • Bitcoin Could Reach $1 Million By 2037, Economist Says: ‘Buy Of A Lifetime’ Opportunity

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsLegalGlobalGeneralFTXSam Bankman-Fried
UBS Logo
UBSUBS Group AG
$37.86-1.51%
Overview
AAPL Logo
AAPLApple Inc
$256.59-0.34%
MS Logo
MSMorgan Stanley
$157.02-2.03%
MSFT Logo
MSFTMicrosoft Corp
$404.96-0.98%
NMR Logo
NMRNomura Holdings Inc
$7.58-1.37%

The jury found that Hwang directed Archegos staff to relay that the firm had large positions in companies such as Apple Inc. (NASDAQ:AAPL) and Microsoft Corp. (NASDAQ:MSFT). Archegos actually invested heavily in a small group of stocks that could be more easily manipulated. 

The collapse at Archegos contributed to the demise of Credit Suisse Group AG and rippled through Wall Street causing significant losses at Morgan Stanley (NYSE:MS), UBS Group AG (NYSE:UBS), Nomura Holdings (NYSE:NMR) and other banks.

UBS Logo
UBSUBS Group AG
$37.86-1.51%
Overview
AAPL Logo
AAPLApple Inc
$256.59-0.34%
MS Logo
MSMorgan Stanley
$157.02-2.03%
MSFT Logo
MSFTMicrosoft Corp
$404.96-0.98%
NMR Logo
NMRNomura Holdings Inc
$7.58-1.37%
Comments
Loading...